Literature DB >> 24334354

Atlantic salmon papillomatosis in Russia and molecular characterization of the associated herpesvirus.

Andor Doszpoly1, Tatiana A Karaseva, Thomas B Waltzek, Ismail M Kalabekov, Igor S Shchelkunov.   

Abstract

Papillomatosis of Atlantic salmon Salmo salar has been reported for decades in Russia, Scandinavia and Scotland. The disease is typically benign although heavy losses have occasionally been reported. A herpesviral etiology has been suggested based on ultrastructural evidence; however, the virus has not been isolated or genetically characterized. In this study, we provide the first viral sequences detected in the papillomas from diseased Russian Atlantic salmon. Phylogenetic analyses, based on the partial sequences of the herpesviral polymerase and terminase genes, supported the virus as a novel member of the genus Salmonivirus within the family Alloherpesviridae. The sequences of the Atlantic salmon papillomatosis virus differ markedly from those of the 3 known salmoniviruses; therefore, the authors propose the species designation Salmonid herpesvirus 4 to be considered for approval by the International Committee on Taxonomy of Viruses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24334354     DOI: 10.3354/dao02674

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  2 in total

1.  Molecular detection of a novel cyprinid herpesvirus in roach (Rutilus rutilus) and asp (Leuciscus aspius) showing typical signs of carp pox disease.

Authors:  Boglárka Sellyei; Ferenc Baska; Ádám Varga; Réka Borzák; Andor Doszpoly
Journal:  Arch Virol       Date:  2020-05-01       Impact factor: 2.574

2.  Development of a loop-mediated isothermal amplification assay for the detection and quantification of epizootic epitheliotropic disease virus (salmonid herpesvirus-3).

Authors:  Qingli Zhang; Megan Shavalier; Isaac Standish; Gavin W Glenney; Thomas P Loch; Mohamed Faisal
Journal:  J Virol Methods       Date:  2018-11-13       Impact factor: 2.014

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.